You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TRK

Showing 26 - 50 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drug-drug Interaction Trial in Tempe (PBI-200 Tablet, Ritonavir Oral Tablet, Cobicistat Oral Tablet)

Completed
  • Drug-drug Interaction
  • PBI-200 Tablet
  • +2 more
  • Tempe, Arizona
    Celerion, Inc.
Jan 11, 2023

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

Recruiting
  • Thyroid Cancer
  • NTRK fusion assessment
  • Roma, Italy
    Regina Elena National Cancer Institute
Mar 31, 2023

Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Worldwide (Oral repotrectinib (TPX-0005))

Recruiting
  • Locally Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Oral repotrectinib (TPX-0005)
  • Yuma, Arizona
  • +175 more
Jan 25, 2023

Healthy, Peripheral Neuropathic Pain Trial in London (TRK-750, Placebo)

Completed
  • Healthy, Peripheral Neuropathic Pain
  • London, United Kingdom
    London
Dec 17, 2018

NTRK Gene Fusion - Positive Advanced or Recurrent Solid

Recruiting
  • Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
  • Larotrectinib (Vitrakvi, BAY2757556)
  • Multiple Locations, Japan
    Many locations
Jan 20, 2023

NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • (no location specified)
Jan 18, 2023

Phase 1, Solid Tumor, Adult Trial in Goyang, Seongnam, Seoul (NOV1601(CHC2014))

Completed
  • Phase 1
  • Solid Tumor, Adult
  • Goyang, Gyeonggi-do, Korea, Republic of
  • +3 more
Sep 8, 2021

NSCLC Stage IV Trial in Gauting (combination regimen tremelimumab /durvalumab, platinum-based chemo (SoC))

Withdrawn
  • NSCLC Stage IV
  • combination regimen tremelimumab /durvalumab
  • platinum-based chemotherapy (SoC)
  • Gauting, Germany
    Asklepios Fachkliniken München-Gauting
Sep 26, 2022

NSCLC, Stage III Trial in Germany (Durvalumab Injection [Imfinzi], Thoracic Radiotherapy (TRT) conventionally, Thoracic

Recruiting
  • NSCLC, Stage III
  • Durvalumab Injection [Imfinzi]
  • +2 more
  • Aachen, Germany
  • +13 more
Nov 29, 2022

Solid Tumors Harboring NTRK Fusion Trial in Worldwide (BAY2757556 (Larotrectinib, Vitrakvi))

Recruiting
  • Solid Tumors Harboring NTRK Fusion
  • BAY2757556 (Larotrectinib, Vitrakvi)
  • Palo Alto, California
  • +158 more
Aug 8, 2022

NSCLC, EGFR Positive NSCLC, Oligoprogression Trial in München (Osimertinib, Radiotherapy)

Recruiting
  • NSCLC
  • +2 more
  • München, Germany
    LMU Klinikum der Universität München
May 17, 2022

Carcinoma,Non-Small-Cell Lung, Metastatic Lung Cancer, Nonsmall Cell Lung Cancer Trial in Germany (Radiotherapy, Nivolumab)

Completed
  • Carcinoma，Non-Small-Cell Lung
  • +4 more
  • Berlin, Germany
  • +15 more
Jan 12, 2021

Adenocarcinoma of the Lung Trial in Großhansdorf (nintedanib-nivolumab combination therapy)

Active, not recruiting
  • Adenocarcinoma of the Lung
  • nintedanib-nivolumab combination therapy
  • Großhansdorf, Germany
    LungenClinic Grosshansdorf
Dec 14, 2021

Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)

Recruiting
  • Metastatic Non-small Cell Lung Cancer (NSCLC)
  • +5 more
  • data collection
  • Oldenburg, Germany
    Pius-Hospital
Jul 20, 2022

Thyroid Carcinoma

Recruiting
  • Differentiated Thyroid Carcinoma
  • Medullary Thyroid Carcinoma
  • Immunohistochemistry (IHC)
  • +2 more
  • L'Hospitalet De Llobregat, Barcelona, Spain
  • +11 more
Mar 22, 2022

Metastatic Squamous NSCLC Trial in Großhansdorf (Pembrolizumab, Placebo)

Terminated
  • Metastatic Squamous Non-small Cell Lung Cancer
  • Großhansdorf, Germany
    LungenClinic Grosshansdorf
Dec 14, 2021

Recurrent Endometrial Cancer, Solid Tumors Trial in Pittsburgh (pembrolizumab, Sitravatinib)

Recruiting
  • Recurrent Endometrial Cancer
  • Solid Tumors
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 12, 2022

Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

Recruiting
  • Bronchial Neoplasms
  • Cologne, Germany
  • +6 more
Nov 2, 2022

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Data and Specimen Collection
  • Boston, Massachusetts
  • +3 more
Feb 22, 2022

NSCLC Trial (Chemotherapy, Alflutinib plus chemo)

Not yet recruiting
  • NSCLC
  • (no location specified)
Jan 25, 2022

Solid Tumors, Lymphomas Trial in Worldwide (TSR-011)

Completed
  • Solid Tumors
  • Lymphomas
  • Goodyear, Arizona
  • +14 more
Mar 25, 2019

Nsclc Trial in Spain (Repotrectinib, Osimertinib)

Recruiting
  • Nsclc
  • Málaga, Andalucia, Spain
  • +3 more
Jun 29, 2022

Solid Tumor Trial in Beijing (TQB3811)

Recruiting
  • Solid Tumor
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Dec 2, 2021

Cancer (With or Without Metastasis) Trial in Houston (TSN084)

Recruiting
  • Cancer (With or Without Metastasis)
  • Houston, Texas
    MD Anderson Cancer Center
Apr 22, 2022